Dr Martens PLC
LSE:DOCS

Watchlist Manager
Dr Martens PLC Logo
Dr Martens PLC
LSE:DOCS
Watchlist
Price: 75.975 GBX 0.56% Market Closed
Market Cap: 734.7m GBX
Section:
 

Relative Value

The Relative Value of one DOCS stock under the Base Case scenario is hidden GBX. Compared to the current market price of 75.975 GBX, Dr Martens PLC is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

DOCS Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

0.9
P/S
P/S
Price to Sales
0.9
vs History
68
vs Industry
56
Median 3Y
1
Median 5Y
1.2
Industry
1
Forward
0.9
More Details
48
P/E
P/E
Price to Earnings
48
vs History
34
vs Industry
32
Median 3Y
12.2
Median 5Y
14
Industry
18
Forward
18.2
More Details
4.8
P/OCF
P/OCF
Price to OCF
4.8
vs History
67
vs Industry
63
Median 3Y
5
Median 5Y
12.5
Industry
10.4
More Details
20.5
P/FCFE
P/FCFE
Price to FCFE
20.5
vs History
14
vs Industry
43
Median 3Y
7
Median 5Y
9.9
Industry
18.3
More Details
2.2
P/B
P/B
Price to Book Value
2.2
vs History
72
vs Industry
35
Median 3Y
2.3
Median 5Y
3.5
Industry
1.3
More Details
1.3
EV/S
EV/S
Enterprise Value to Sales
1.3
vs History
68
vs Industry
46
Median 3Y
1.3
Median 5Y
1.6
Industry
1.2
Forward
1.2
More Details
1.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.9
vs History
68
vs Industry
66
Median 3Y
2
Median 5Y
2.6
Industry
3.9
More Details
5.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
5.5
vs History
80
vs Industry
53
Median 3Y
6.3
Median 5Y
6.7
Industry
9.6
Forward
6.3
More Details
9.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
9.4
vs History
67
vs Industry
40
Median 3Y
9.8
Median 5Y
10.7
Industry
13.2
Forward
12.1
More Details
6.4
EV/OCF
EV/OCF
Enterprise Value to OCF
6.4
vs History
67
vs Industry
59
Median 3Y
6.9
Median 5Y
13.5
Industry
11.4
More Details
7.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
7.1
vs History
73
vs Industry
49
Median 3Y
8.3
Median 5Y
16.9
Industry
14.9
More Details
1.5
EV/IC
EV/IC
Enterprise Value to IC
1.5
vs History
72
vs Industry
37
Median 3Y
1.6
Median 5Y
2.1
Industry
1
More Details

Multiples Across Competitors

DOCS Competitors Multiples
Dr Martens PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Dr Martens PLC
LSE:DOCS
734.2m GBP 0.9 48 5.5 9.4
US
Nike Inc
NYSE:NKE
98.6B USD 2.1 34.1 23.4 28.7
JP
Asics Corp
TSE:7936
2.7T JPY 3.6 35.6 18.1 21.5
CH
On Holding AG
NYSE:ONON
15.8B USD 4.4 56.2 25.9 34.9
US
Deckers Outdoor Corp
NYSE:DECK
14.7B USD 2.8 14.5 10.2 10.8
CN
Huali Industrial Group Co Ltd
SZSE:300979
67.7B CNY 2.7 19.7 14.1 14.1
US
Skechers USA Inc
NYSE:SKX
9.5B USD 1 14.3 7.8 9.9
UK
Birkenstock Holding PLC
NYSE:BIRK
8.3B USD 3.5 23 12.5 15.2
US
Crocs Inc
NASDAQ:CROX
4.7B USD 1.2 25.7 5.7 6.2
TW
Feng Tay Enterprises Co Ltd
TWSE:9910
117.9B TWD 1.4 22.7 11.7 16.3
DE
Puma SE
XETRA:PUM
3.1B EUR 0.4 -33 10.3 10.3
P/E Multiple
Earnings Growth PEG
UK
Dr Martens PLC
LSE:DOCS
Average P/E: 29.4
48
146%
0.3
US
Nike Inc
NYSE:NKE
34.1
12%
2.8
JP
Asics Corp
TSE:7936
35.6
24%
1.5
CH
On Holding AG
NYSE:ONON
56.2
34%
1.7
US
Deckers Outdoor Corp
NYSE:DECK
14.5
6%
2.4
CN
Huali Industrial Group Co Ltd
SZSE:300979
19.7
7%
2.8
US
Skechers USA Inc
NYSE:SKX
14.3
1%
14.3
UK
Birkenstock Holding PLC
NYSE:BIRK
23
35%
0.7
US
Crocs Inc
NASDAQ:CROX
25.7
-12%
N/A
TW
Feng Tay Enterprises Co Ltd
TWSE:9910
22.7
5%
4.5
DE
Puma SE
XETRA:PUM
Negative Multiple: -33
-36%
N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
Dr Martens PLC
LSE:DOCS
Average EV/EBITDA: 13.2
5.5
10%
0.5
US
Nike Inc
NYSE:NKE
23.4
11%
2.1
JP
Asics Corp
TSE:7936
18.1
20%
0.9
CH
On Holding AG
NYSE:ONON
25.9
40%
0.6
US
Deckers Outdoor Corp
NYSE:DECK
10.2
4%
2.5
CN
Huali Industrial Group Co Ltd
SZSE:300979
14.1
14%
1
US
Skechers USA Inc
NYSE:SKX
7.8
2%
3.9
UK
Birkenstock Holding PLC
NYSE:BIRK
12.5
18%
0.7
US
Crocs Inc
NASDAQ:CROX
5.7
-7%
N/A
TW
Feng Tay Enterprises Co Ltd
TWSE:9910
11.7
10%
1.2
DE
Puma SE
XETRA:PUM
10.3
-15%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
UK
Dr Martens PLC
LSE:DOCS
Average EV/EBIT: 16.1
9.4
18%
0.5
US
Nike Inc
NYSE:NKE
28.7
14%
2
JP
Asics Corp
TSE:7936
21.5
N/A N/A
CH
On Holding AG
NYSE:ONON
34.9
46%
0.8
US
Deckers Outdoor Corp
NYSE:DECK
10.8
4%
2.7
CN
Huali Industrial Group Co Ltd
SZSE:300979
14.1
7%
2
US
Skechers USA Inc
NYSE:SKX
9.9
-1%
N/A
UK
Birkenstock Holding PLC
NYSE:BIRK
15.2
20%
0.8
US
Crocs Inc
NASDAQ:CROX
6.2
-6%
N/A
TW
Feng Tay Enterprises Co Ltd
TWSE:9910
16.3
10%
1.6
DE
Puma SE
XETRA:PUM
10.3
-24%
N/A

See Also

Summary
DOCS intrinsic value, competitors valuation, and company profile.
DCF Valuation
DOCS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DOCS stock valuation using valuation multiples.
Wall Street Estimates
DOCS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DOCS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 302,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.